Breast Cancer News

A cohort study published in JAMA Oncology found substantial state variations in racial and ethnic disparities in triple-negative breast cancer incidence, with Black women in four states having the highest rates.

Today marks International Women’s Day.

Breast cancer stage and receptor status appeared to predict risk for recurrence among patients with stage I to stage III disease, according to study results published in Cancer.

Local administration of chimeric antigen receptor T cells via a fibrin-based gel effectively eliminated leftover cancer cells after incomplete surgical resection, study results published in Science Advances showed.

Researchers at Cleveland Clinic intend to expand their study of a novel vaccine designed to prevent triple-negative breast cancer.

The FDA expanded the approval of abemaciclib, combined with endocrine therapy, as adjuvant treatment for adults with hormone receptor-positive, HER2-negative, node-positive early breast cancer.

Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.

Private sector workers in the United States had a higher likelihood of undergoing colorectal or breast cancer screening if they lived in a jurisdiction with a paid-sick-leave mandate, results of a population-based study showed.

Women who had surgery up to 8 weeks after breast cancer diagnosis did not have worse overall survival than those with earlier times to surgery, according to a case series with more than 373,000 women published in JAMA Surgery.

Direct oral anticoagulants showed greater efficacy and cost-effectiveness than low-molecular-weight heparin for treatment of cancer-associated thrombosis, according to data published in Annals of Internal Medicine.